New apalutamide study opens for prostate cancer

February 14, 2018

A new phase 3 study at Providence Cancer Institute will compare the effectiveness of three different treatment regimens in men with biochemically recurrent prostate cancer:

Experimental arm: apalutamide, an investigational, next-generation oral androgen receptor (AR) inhibitor, plus degarelix, a hormonal therapy used to reduce testosterone
Experimental arm: apalutamide and degarelix plus abiraterone acetate and prednisone
Control arm: degarelix alone

“Apalutamide (ARN-509) reduced the risk of metastasis or death by 72% in patients with nonmetastatic castration-resistant prostate cancer,” according to findings from the phase 3 SPARTAN trial reported in OncLive on Feb. 5. The SPARTAN trial, published in the New England Journal of Medicine on Feb. 8, found that “median metastasis-free survival was more than 2 years longer” for men who received apalutamide. Read more in the New York Times.

Brendan Curti, M.D., the principal investigator of the new three-arm study at Providence Cancer Institute, is a medical oncologist and director of genitourinary oncology research at the Earle A. Chiles Research Institute.

See Providence study details here:

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

More prostate cancer studies

This study is one of three clinical trials open to men with prostate cancer at Providence Cancer Institute. See all prostate cancer studies.

To refer patients to any of these studies, call Providence Cancer Institute’s Clinical Research office at 503-215-2614 or visit oregon.providence.org/clinical-trials.

Welcome to your journey for creating a healthier you

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

Most Recent Articles

Ongoing research and clinical trials are creating breakthroughs in cancers once thought insurmountable—and St. Jude is a leader in bringing these benefits from the lab to the bedside.

Providence contributes to Los Angeles County efforts to ensure care for vulnerable populations as COVID-19 crisis escalates

Responding to the unprecedented challenge fighting coronavirus disease 2019 (COVID-19), the U.S. Government is supporting a national Expanded Treatment Protocol to collect convalescent plasma.

Providence Seward Medical & Care Center has partnered with Seward Community Health Center and the Alaska SeaLife Center to offer drive-through testing for COVID-19.

As COVID-19 (coronavirus) continues to spread within the U.S., we are taking every precaution to keep our patients, our caregivers and our community safe.

An annual Chains of Caring linking ceremony is scheduled for noon on Friday, Feb. 28, in the Providence Health Park Healing Arts Alcove.

Providence Health & Services Alaska has opened a new primary care clinic in Anchorage, Providence Medical Group Primary Care Huffman. The new clinic is located at 1389 Huffman Park Drive, Suite 202.

Anchorage area IHOP restaurants will offer each guest a free short stack of their famous buttermilk pancakes on National Pancake Day, Tuesday, Feb. 25.

Providence Express Care and Express Care Virtual services are now available for Alaskans. The newest Express Care clinic recently opened in Eagle River, joining four locations in Anchorage.

Providence Medical Group Primary Care has received recertification as a Patient-Centered Medical Home (PCMH) from the National Committee for Quality Assurance.

Providence Extended Care and Providence Seward Mountain Haven have been recognized as among the best nursing homes in the country in the U.S. News & World Report 2019-20 nursing home ratings.

Providence St. Joseph Health announced today – through the St. Joseph Community Partnership Fund – it will contribute $500,000 to help not-for-profit community partners respond to the challenges of th

At Providence Little Company of Mary Medical Center Torrance, a surgeon gives patients a new and improved life.

When Brian Hong was transferred from another hospital to St. Jude Medical Center’s Critical Care Unit, he was completely paralyzed, unable to speak or breath on his own. His prognosis was poor.

Dear St. Jude family, Words cannot fully express my gratitude for your heartfelt support of our patients and families over the last year.

The physicians at St. Jude offer a level of expertise and compassion that has helped make us one of Southern California’s most advanced and respected medical centers.

Thanks to your thoughtful generosity which had a total philanthropic impact of $3 million in 2019, St. Jude continues to excel as one of the top hospitals in Southern California.

Galo Franco turned to Providence Little Company of Mary’s Bariatric Wellness Center to get the help he needed. Today he runs races, sleeps better and feels better than ever.

It’s a mistake that can lead to permanent damage to your hand. Carpal tunnel syndrome (CTS) is the result of pressure on the median nerve as it travels through the wrist.

Providence St. Joseph Medical Center, with the help from the Providence Montana Health Foundation added new digital x-ray equipment to the Diagnostic Imaging Department. Ancillary Services Manager Ada